Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR® (montelukast sodium) Tablets, Chewable Tablets, and Oral GranulesInitial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
SINGULAIR® is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. SINGULAIR is indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 15 years of age and older. SINGULAIR is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older.
- generic_name
- montelukast sodium
- product_names
- montelukast sodium
- ndc
- 54868-4630, 0006-0711, 54868-4630-0, 54868-4847, 0006-0275, 54868-4847-0, 54868-3283, 0006-0117, 54868-3283-1, 54868-3283-2
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en